Aggressive management of obesity in children and young adults: The known challenges and potential opportunities

Clinical Pharmacology and Therapeutics

Volumn 81, Issue 5, 2007, Pages 627-630

  Barter, P J ^a   Shear, C L ^b  

^a HEART RESEARCH INSTITUTE   (Australia)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; CAFFEINE; CANNABINOID RECEPTOR ANTAGONIST; CP 945 598; DEXFENFLURAMINE; EPHEDRINE; FENFLURAMINE; FLUOXETINE; HORMONE ANTAGONIST; KRP 204; LEPTIN; MK 0364; NORADRENALIN UPTAKE INHIBITOR; PRAMLINTIDE; RIMONABANT; SEROTONIN AGONIST; SUCROSE POLYESTER; TETRAHYDROLIPSTATIN; UNCLASSIFIED DRUG;

CHILDHOOD DISEASE; EPIDEMIC; HUMAN; OBESITY; PREVALENCE; PRIORITY JOURNAL; REVIEW;

ADOLESCENT; ADULT; CARDIOVASCULAR DISEASES; CHILD; HUMANS; OBESITY;

EID: 34247259016     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/sj.clpt.6100162     Document Type: Review

References (21)

1. Poirier, P. et al. Obesity and cardiovascular disease: pathophysiology, evaluatiTon, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113, 898-918 (2006).
2. Daniels, S.R. et al. Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. Circulation 111, 1999-2012 (2005).
3. Dietz, W.H. Health consequences of obesity in youth: childhood predictors of adult disease. Pediatrics 101, 518-525 (1998).
4. Wyatt, S.B., Winters, K.P. & Dubbert, P.M. Overweight and obesity: prevalence, consequences, and causes of a growing public health problem. Am. J. Med. Sci. 331, 166-174 (2006).
5. Hill, J.O. Understanding and addressing the epidemic of obesity: an energy balance perspective. Endocr. Rev. 27, 750-761 (2006).
6. Lustig, R.H. The neuroendocrinology of childhood obesity. Pediatr. Clin. North Am. 48, 909-930 (2001).
7. Klaus, S. Adipose tissue as a regulator of energy balance. Curr. Drug Targets 5, 241-250 (2004).
8. Prentice, A. & Jebb, S. Energy intake/physical activity interactions in the homeostasis of body weight regulation. Nutr. Rev. 62, S98-S104 (2004).
9. Schrauwen, P. & Westerterp, K.R. The role of highfat diets and physical activity in the regulation of body weight. Br. J. Nutr. 84, 417-427 (2000).
10. Haslam, D.W. & James, W.P. Obesity. Lancet 366, 1197-1209 (2005).
11. Ebbeling, C.B., Pawlak, D.B. & Ludwig, D.S. Childhood obesity: public-health crisis, common sense cure. Lancet 360, 473-482 (2002).
12. Lobstein, T., Baur, L. & Uauy, R. Obesity in children and young people: a crisis in public health. Obes. Rev. 5 (suppl. 1), 4-104 (2004).
13. Summerbell, C.D., Waters, E., Edmunds, L.D., Kelly, S., Brown, T. & Campbell, K.J. Interventions for preventing obesity in children. Cochrane Database Syst. Rev. CD001871 (2005).
14. Fujioka, K. Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical options. Obes. Res. 10 (suppl. 2), 116S-123S (2002).
15. Yach, D., Stuckler, D. & Brownell, K.D. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat. Med. 12, 62-66 (2006).
16. Grundy, S.M. et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110, 227-239 (2004).
17. Brown, M.S. & Goldstein, J.L. Biomedicine. Lowering LDL-not only how low, but how long? Science 311, 1721-1723 (2006).
18. Cohen, J.C., Boerwinkle, E., Mosley, T.H., Jr. & Hobbs, H.H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med. 354, 1264-1272 (2006).
19. Ells, L.J., Campbell, K., Lidstone, J., Kelly, S., Lang, R. & Summerbell, C. Prevention of childhood obesity. Best Pract. Res. Clin. Endocrinol. Metab. 19, 441-454 (2005).
20. Foster-Schubert, K.E. & Cummings, D.E. Emerging therapeutic strategies for obesity. Endocr. Rev. 27, 779-793 (2006).
21. Das, S.K. & Chakrabarti, R. Antiobesity therapy: emerging drugs and targets. Curr. Med. Chem. 13, 1429-1460 (2006).